Pfizer Inc. (PFE) Announces 70 Million Encysive (ENCY) Shares Tendered
Pfizer Inc. (NYSE: PFE) today announced results of its tender offer by its wholly-owned subsidiary, Explorer Acquisition Corp., to purchase all outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ: ENCY) at a purchase price of $2.35 per share. Pfizer announced that a total of 70,238,869 shares, approximately 86.8 percent of the outstanding shares, including 8,473,574 shares subject to guarantees of delivery, were tendered and not withdrawn prior to the expiration of the initial offering period March 31, 2008, expired April 3, 2008. As of April 1, 2008, Pfizer beneficially owned approximately 64,128,679 shares, which is about 79.22 percent…